LAIR2 and cancer: Using scRNASeq of TILs from LUAD, we found that LAIR2 was predominantly expressed by tumor-associated CD4+ FoxP3+ Treg cells (Figure 4), the presence of which have widely been associated with negative outcomes in a variety of cancers [11,12,13].